Australia markets closed

Cassava Sciences, Inc. (SAVA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
34.92+1.28 (+3.80%)
At close: 01:00PM EST
34.95 +0.03 (+0.09%)
After hours: 04:58PM EST
Full screen
Loading interactive chart…
  • GlobeNewswire

    Cassava Sciences Announces Closing of $50 Million Registered Direct Offering

    AUSTIN, Texas, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced the closing of its previously announced registered direct offering of 1,666,667 shares of its common stock, at a purchase price per share of $30, for gross proceeds of approximately $50 million. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. JonesTrading

  • GlobeNewswire

    Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock

    AUSTIN, Texas, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that it has entered into a definitive agreement with several healthcare-focused and other institutional investors for the purchase of 1,666,667 shares of its common stock, at a purchase price of $30 per share, for gross proceeds of approximately $50 million, in a registered direct offer

  • Yahoo Finance Video

    Cassava Sciences stock pops after rival experiences setback in Alzheimer’s research

    Shares of Cassava are moving higher on news that its rival Roche suffered a setback in its Alzheimer's drug research trial.